| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |